Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells

Area of Science:

• Neuropharmacology
• Biochemistry
• Cell Biology

Background:

• Clonidine-displacing substance (CDS) has been previously extracted from NG108-15 cell lines.
• Further purification and characterization of CDS are essential to understand its nature and potential variations across tissues.

Purpose of the Study:

• To further purify CDS from the NG108-15 cell line using reverse-phase high-performance liquid chromatography (RP-HPLC).
• To compare the purified CDS from NG108-15 cells with CDS from other tissues to identify similarities or differences.
• To investigate the existence of multiple forms of CDS.

Main Methods:

• Crude CDS extraction from NG108-15 cells.
• Fractionation of CDS using RP-HPLC with a methanol gradient.
• Determination of pharmacological activity by assessing the displacement of [3H]clonidine from alpha(2)-adrenoceptors in rat brain membranes.

Main Results:

• A distinct pharmacologically active CDS fraction was identified via RP-HPLC, eluting at 24 minutes.
• This active fraction was separate from agmatine.
• The RP-HPLC elution profile indicated that the NG108-15 cell line CDS is more hydrophobic than CDS extracted from bovine tissues.

Conclusions:

• CDS is present in the NG108-15 cell line.
• The physicochemical properties of CDS from NG108-15 cells differ from those of bovine CDS.
• These findings support the hypothesis that multiple distinct forms of CDS exist.